Probmet is a precision oncology therapeutics company that is developing targeted treatments for breast cancer brain metastatic patients. The team will lead the development of breakthrough targeted therapies for metastatic breast cancer in the brain, a devastating disease that currently has limited treatment options.
Company Details
- Employees
- 2
- Founded
- 2022
- Address
- Ole Maaløes Vej 3, 2200, Copenhagen,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.probmet.com
- HQ
- Copenhagen
Probmet Therapeutics Questions
Probmet Therapeutics's website is http://www.probmet.com
Probmet Therapeutics's LinkedIn profile is https://dk.linkedin.com/company/probmettherapeutics
Probmet Therapeutics has
2 employees.
View email and phone details for 2
employees at Probmet Therapeutics.
Probmet Therapeutics's industry is
Biotechnology Research
Probmet Therapeutics's top competitors are
Inreality,
Epoqe Pharma Aps,
Kesmalea Therapeutics,
Cirqle Biomedical,
Cell To Cure Aps,
Cellgebra,
Solid Therapeutics,
Xy Therapeutics,
Loma Therapeutics,
Boost Pharma.
Probmet Therapeutics's categories are Biotechnology Research
Probmet Therapeutics's founding year is 2022
